BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ghazanfar H, Javed N, Qasim A, Sosa F, Altaf F, Khan S, Mahasamudram J, Jyala A, Kandhi SD, Shin D, Mantri N, Sun H, Hanumanthu S, Patel H, Makker J, Balar B, Dev A, Chilimuri S. Is it necessary to stop glucagon-like peptide-1 receptor agonists prior to endoscopic procedure? A retrospective study. World J Gastroenterol 2024; 30(26): 3221-3228 [PMID: 39086638 DOI: 10.3748/wjg.v30.i26.3221]
URL: https://www.wjgnet.com/1007-9327/full/v30/i26/3221.htm
Number Citing Articles
1
Sahib Singh, Saurabh Chandan, Dushyant Singh Dahiya, Ganesh Aswath, Daryl Ramai, Marcello Maida, Andrea Anderloni, Nicola Muscatiello, Antonio Facciorusso. Impact of GLP-1 Receptor Agonists in Gastrointestinal Endoscopy: An Updated ReviewJournal of Clinical Medicine 2024; 13(18): 5627 doi: 10.3390/jcm13185627
2
Ronald M. Goldenberg, Jeremy D. Gilbert, Robyn L. Houlden, Tayyab S. Khan, Sapna Makhija, C. David Mazer, Jill Trinacty, Subodh Verma. Perioperative and periprocedural management of GLP-1 receptor-based agonists and SGLT2 inhibitors: narrative review and the STOP-GAP and STOP DKA-2 algorithmsCurrent Medical Research and Opinion 2025; : 1 doi: 10.1080/03007995.2025.2458538
3
Thomas A Elimihele, Anjali M Mangrola, Oluwatobi Oshomoji, Nateshia B Wilson, Ikenna Nnamani, Bryan Ashong, Sunteasja Billings, Daniel K Getu, Sachin Kumar, Benedict Maliakkal. Confounding Factors in the Association Between Glucagon-Like Peptide-1 Receptor Agonist Use and Retained Gastric Contents in Asymptomatic Patients Undergoing Upper Gastrointestinal Endoscopy: A Retrospective StudyCureus 2024;  doi: 10.7759/cureus.69152